wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33422258-2EFCA451-1D09-4162-9EA2-F05CE93FAD79
Q33422258-2EFCA451-1D09-4162-9EA2-F05CE93FAD79
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33422258-2EFCA451-1D09-4162-9EA2-F05CE93FAD79
Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy.
P2860
Q33422258-2EFCA451-1D09-4162-9EA2-F05CE93FAD79
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33422258-2EFCA451-1D09-4162-9EA2-F05CE93FAD79
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
27b269ef3ab22a069302766eacd99fb1ffaa42c5
P2860
A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancer.